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EXPERIMENTAL and pathological in-
vestigations have shown asbestos to be
associated with mesothelioma in animals
and man (Wagner & Berry, 1969; Wagner
et al., 1960). In man the development of
this neoplasm can take as long as 30-40
years after the first exposure to asbestos
(Selikoff & Lee, 1978) and a comparable
long latency period (18 months to 2 years)
is found in rats.
Immunogenic tumour-associated trans-
plantation antigens (TATA) are expressed
on chemically induced tumours such as
3-methyleholanthrene-induced fibrosar-
comas in mice (Prehn & Main, 1957) and
rats (Baldwin, 1955a). However, asbestos
is a mineral the physical properties of
which are a major factor in determining
its carcinogenic potential (Stanton et al.,
1977). Our experiments, therefore, were
undertaken to establish the presence or
absence of TATA on transplantable
asbestos-induced mesotheliomas. In vivo
assessment of TATA was studied using
excision challenge and irradiated-graft
regimes.
Syngeneic PVG/C Norwegian hooded
rats, obtained from Glaxo Laboratories,
Greenford, Middlesex, were housed in
barrier-maintained conditions. Twenty-
six males and 17 females between 6 and
7 weeks of age were given intrapleural in-
jection of 20 mg of UICC crocidolite in
0 4 ml of saline (Wagner & Berry, 1969).
The tumours were transplanted and main-
tained by s.c. serial passage for an average
of 20 generations using a trocar implanta-
tion method as described by Baldwin
(1955b). Seven tumour lines, 5 of male and
2 of female origin, have been established.
As the tumours arose, they were desig-
nated Mel, Me2, as shown in Table I. Nine
tumours were transplanted, 2 ofwhich are
not included in this study (one was lost
due to rapid host death; another was in-
appropriately designated Me8, and after
histological identification was redesig-
nated ADC1). The primary morphology of
the 7 remaining tumours on histological
examination showed the typical di-
morphic pattern of both epithelial and
spindle-cell types. One tumour was of
predominantly spindle-cell type.
By the 4th transplant generation (TG)
all but 2 ofthe tumours became dominated
by large undifferentiated primitive cells
with a high mitotic rate. All tumours
showed this morphology after 6 TGs.
Routine histological examination of the
lungs from these animals carrying primary
tumour revealed the features of chronic
murine bronchitis, the increase in lymph-
oid tissue being most marked when the
tumour had compressed the bronchi.
Untreated animals also had bronchitis.
The changes arose in spite of no patho-
genic organisms having been found on
bacteriological examination.
Transplantation of tumours was carried
out between animals that were no more
than 4 generations removed from common
ancestry, 6 months of age or less and of
the same sex.
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TABLE I.-In vivo assessment of mesothelioma immunogenicity
No. tumour takes/No. rats injected
Mesotheliomas
AMel (TG18-21)
Mee2 (TG16-19)
Mle4 (TG3-7)
Me5 (TG13-16)
AMe6 (TG6-8)
Me7 (TG6-8)
Ale9 (TG13-15)
Adenocarcinoma
ADCI (TG9- 11)
Sham Irradiated
Controls Excision excision tumour
Dose (a) (b) (c) (d)
1 x 105
2-5 x 105
5 x 105
1 X 104
5 x 105
I x 105
2 x 105
1 x 105
1 X l0
6/6
4/6
3/3
6/6
6/6
:3/6
6/6
6/6
6/6
6/6
7/7
ND
3/4
6/7
0/2
5/7
ND
8/8
7/7
7/7
ND
8/8
6/6
2/6
4/4
ND
7/8
8/8
5/8
3/3
7/7
8/8
1/6
4/5
7/7
5/8
Irradiated
lung
(e)
7/7
8/8
ND
7/7
6/8
2/6
4/4
6/6
7/8
1 x 105 6/6 0/7 0/7 5j6 7/8
2X 105 6/6 7/7 5/5 ND ND
TG=Transplant generation.
ND =Expt not clone.
(ADC1) was found in a crocidolite-treated
rat with no signs of a mesothelioma. This
tumour was maintained as a control for the
mesothelioma study.
The immunization regimes were based
on those described by Baldwin & Barker
(1967). Five groups of comparable rats
(5-8 animals/group) were used for each
transplanted tumour:
Group (a). Unsensitized "normal
animals" were used as direct controls.
Different rats were used for each subse-
quent tumour challenge.
Group (b). Surgical excision of s.c.
tumour when the growth attained an
average size of 3 x 1P5 cm.
Group (c).-Surgical excision control
(sham). Diced normal adult lung was
given s.c. at the same time as the im-
munizing tumour was given to Group (b).
The tissue was excised concurrently with
Group (b).
Group (d). Irradiated tumour grafts
(100-150 Gy). Three s.c. irradiated tumour
fragments were given at intervals of 2
weeks.
Group (e). Irradiated graft controls.
Normal adult lung was diced, irradiated
and administered in an identical way to
the tumour graft of Group (d).
All animals were challenged 7-10 days
after completion of the immunization
regime with the minimum dose of tumour
cells needed to form a palpable tumour
within 30 days. The dose is shown in the
second column in Table I, and had been
estimated for each tumour in a separate
experiment. These estimates were ob-
tained by a series of doses (i.e. 102, 103,
5 X 103, 104, 5 x 104, 105, 2 x 105, 2-5 x 105,
4 x 105, 5 x 105, 106). The minimum dose
of cells which repeatedly gave 100% takes
in control animals was used. Single
tumnour-cell suspensions were obtained as
described by Baldwin (1966). The cell
viability of the suspension was measured
in fluorescein-diacetate-treated cells
(Parazzi et al., 1968) counted in a Fuchs-
Rosenthal Haemocytometer. The animals
in all groups were "scored" 30 days after
tumour challenge. Absence of tumour was
read as rejection. In Table I the number of
tumour "takes" over the total number of
animals per group is given. The upper
limit of immunity was estimated bv
doubling the previous dosage until all the
animals in Groups (b) and (d) had palpable
tumours.
The immunocompetence of the rats,
using both in vivo and in vitro assays after
a strong immunogenic stimulus, was
assayed. These assays were as follows:
1. Positive control tumour. Strongly
immunogenic tumours were induced by
s.c. injection of 10 mg of 3-methylchol-
anthrene in 0 5 ml of Tricaprylin. Identi-
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TABLE II.-Imrmunogenicity of 3-methylcholanthrene-induced fibrosarcomas
Dose
1 X 105
2 x 105
4 x 105
8 x 105
Mlc3 (TG3-5) 5 x 104
1 X 105
2 x 105
5x 105
1 x 106
ND =Expt not (lone.
No. tumour takes/No. rats injected
Sham Irradiated Irradiated
Controls Excision excision ttumouir lung
(a) (b) (c) (d) (e)
6/6 0/8 6/8 0/8 7/8
6/6 2/8 2/2 3/8 ND
5/6 1/6 ND 1/5 ND
6/6 5/5 ND 4/4 ND
4/6
6/6
6/6
6/6
6/6
cal immunization regimes to the experi-
mental tumours were followed.
2. Allogeneic skin transplants (Festing
et al., 1970). Skin grafts ofFischer 344 rats
to PVG/c were undertaken to establish
immunocompetence. Isografts between
members of the colony acted as controls.
3. Plaque-forming colonies estimation
(Jerne et al., 1963; Cunningham, 1965).
4. Cell-mediated immune reactivity to
purified protein derivative (PPD) of
Bacillus Calmette-Guerin (BCG). Re-
activity to 25 /ig of preservative-free PPD
(Ministry ofAgriculture, Fisheries & Food
Laboratories, Weybridge, Surrey) injected
i.d. in the right ear in rats pre-immunized
2 weeks earlier with 50 pul of percutaneous
BCG (Glaxo Laboratories, Greenford,
Middlesex) reconstituted in 0 3 ml of dis-
tilled water. The BCG was injected i.m.
in the right hind leg. A measurement of
ear thickness was made with a micrometer
at 24 and 48 h after PPD challenge and a
comparison made with the untreated left
ear. A 50% increase in ear thickness when
compared to the left ear was taken as a
positive result.
Table I summarizes the immunogenic
potential of the rat mesothelioma using
the immunization methods described. Five
tumours failed to reject the minimum
inoculum dose of tumour cells in both the
excision and irradiated-graft regimes. The
failure of all the control animals in Me2
and Me6 to succumb to tumour growth
was overcome by doubling the previous
0/8
0/8
0/8
2/8
6/6
1/8
7/7
ND
ND
ND
0/8
0/8
1/7
1/6
5/5
5/8
3/3
ND
ND
ND
dose. Some resistance to the adenocarcin-
oma (ADCI) was apparent. The failure of
the sham excision Group (c) (which had
received implants of normal lung tissue)
to succumb to tumour growth implies that
TATA were not involved.
In contrast to the mesotheliomas,
identical immunization regimes for the
3-methylcholanthrene-induced fibrosar-
comas (Mc) did produce measurable re-
sistance to challenge. Table II shows that
immunity to 4 x 105 Mcl cells and 5 x 105
Mc3 cells was demonstrated. This repre-
sents resistance to at least a 4-fold increase
above the minimum inoculation dose
necessary for tumour production in non-
sensitized rats. Our findings are in agree-
ment with the results in other laboratories,
that strongly immunogenic TATA are
expressed in these fibrosarcomas.
Results of immunocompetence tests
were compared to the responses of a rat
colony maintained at Nottingham Univer-
sity Cancer Research Laboratories (M. J.
Embleton, personal communication).
Briefly, the mean right ear thickness of
6 animals given BCG followed by PPD i.d.
was 1P40 mm + 0414 mm (mean+s.d.) as
compared with a left ear thickness of
0-76 + 0 05 mm. Using the paired t test, the
difference was shown to be significant
(P < 0.001, t= -121] with 5 d.f.). Agrouped
t test applied to the results of the Jerne
Plaque Assay gave the same significant
probabilitylevel.Agroupof5 maleratsgave
a group mean of 54-0 + 12-2 plaques/105
M\el (TG7- 1)
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splenic lymphocytes. The same number of
control animals gave 33 + 1P2 plaques/105
lymphocytes. Similarly, 5 females gave
group means of 64 2 + 34 8 and 23 + 1 8
for control animals. Seven of 10 allo-
grafts were rejected at 21 days. Three
grafts sloughed off after 2-3 days; 9 of 10
isografts from comparable donors were
successfully grafted. We were satisfied
that both in vivo and in vitro immune
competence had been demonstrated.
Embleton et al. (1976) tested allogeneic
human mesothelioma cells in an in vitro
lymphocytotoxicity test and reported a
negative result. This in vivo study of rat
mesothelioma immunogenicity also re-
ports negative findings.
When present, in vivo rejection of
tumour as measured by the excision/
challenge assay is indicative of immuno-
genic cell-surface antigen expression, as
demonstrated in the 3-methylehol-
anthrene-induced fibrosarcoma. Smith &
Landy (1974), amongst others, have
pointed out that negative results may
arise owing to quantitative or qualitative
lack of antigen expression, antigenic loss
ormodulation, orincorrecttimeoftumour-
cell challenge for the peak level of host
immunity. A serologically defined glyco-
protein specific for human mesothelioma
cells and normal mesothelial cells has been
described (Singh et al., 1979) which, if
present in rats, is obviously not immuno-
genic when tested by the methods used in
our experiment.
Kanazawa et al. (1979) have suggested
that even low levels of asbestos-dust ex-
posure can enhance or modulate suscepti-
bility of young mice to murine-sarcoma-
virus-induced oncogenesis. Arnold et al.
(1976) have indeed shown that in ham-
sters Papova virus will induce mesotheli-
omas. Tumours arising as a result of viral
involvement are typified by cross-reacting
cell-surface antigens capable of eliciting
strong tumour rejection responses as meas-
ured by excision/challenge assay (Sjogren,
1961). We present no evidence of such a
strong response to support viral synergism
in the production of mesotheliomas.
The work described in this paper sup-
ports the general concept of the inability
oflong-latent-period tumours to stimulate
host rejection through cell-surface ex-
pression of TATA. However, equal con-
sideration must be given to the fact that a
carcinogen was used the physical proper-
ties ofwhich are important. This agent has
not yet been shown to be immunosup-
pressive in vivo, nor have its mutagenic
properties been confirmed.
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